Literature DB >> 20090572

R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins.

Robert A Brown1, Jonathon H Gralewski, Albert J Eid, Bettina M Knoll, Robert W Finberg, Raymund R Razonable.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) core and nonstructural (NS) 3 proteins induce inflammation and immunity through a toll-like receptor (TLR) 2-dependent pathway. Individuals with the R753Q single-nucleotide polymorphism (SNP) in the TLR2 gene have increased the risk of allograft failure after liver transplantation for chronic hepatitis C.
METHODS: To test the hypothesis that R753Q SNP impairs TLR2 recognition of HCV proteins, a series of in vitro experiments were performed wherein stable clones of wild-type TLR2-deficient human embryonic kidney (HEK) 293 cells and HEK293 cells transfected with wild-type (HEK293-TLR2) or variant TLR2 genes (HEK293-TLR2-R753Q) were stimulated with HCV core and NS3 proteins. Cellular activation was assessed by nuclear factor-kappa B-driven luciferase activity, cytokine secretion, and gene upregulation.
RESULTS: Compared with TLR2-deficient HEK293 cells, HEK293-TLR2 cells had marked nuclear factor-kappa B-driven luciferase activity, had modest to marked upregulation in TLR2 signaling-associated genes, and secreted large quantities of interleukin-8 during exposure to HCV core and NS3 proteins. In contrast, HEK293-TLR2-R753Q cells did not respond to stimulation with HCV and behaved similarly like TLR2-deficient HEK293 cells.
CONCLUSION: R753Q SNP impairs TLR2-mediated immune recognition of HCV core and NS3 proteins. This biologic defect may account for the predisposition of patients to develop allograft failure after liver transplantation for chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090572      PMCID: PMC2857328          DOI: 10.1097/TP.0b013e3181cbac18

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  27 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.

Authors:  N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.

Authors:  R Sreekumar; A Gonzalez-Koch; Y Maor-Kendler; K Batts; L Moreno-Luna; J Poterucha; L Burgart; R Wiesner; W Kremers; C Rosen; M R Charlton
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

4.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

6.  Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.

Authors:  Timothy McCashland; Kymberly Watt; Elizabeth Lyden; Leon Adams; Michael Charlton; Alastair D Smith; Brendan M McGuire; Scott W Biggins; Guy Neff; James R Burton; Hugo Vargas; John Donovan; James Trotter; Thomas Faust
Journal:  Liver Transpl       Date:  2007-09       Impact factor: 5.799

Review 7.  Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids.

Authors:  Nicolas W J Schröder; Jana Eckert; Gunthard Stübs; Ralf R Schumann
Journal:  Immunobiology       Date:  2008-01-02       Impact factor: 3.144

8.  The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus.

Authors:  Robert A Brown; Jonathon H Gralewski; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

9.  The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.

Authors:  Raymund R Razonable; Kelly W Burak; Hester van Cruijsen; Robert A Brown; Michael R Charlton; Thomas F Smith; Mark J Espy; Walter Kremers; Jennie A Wilson; Cynthia Groettum; Russell Wiesner; Carlos V Paya
Journal:  Clin Infect Dis       Date:  2002-09-26       Impact factor: 9.079

10.  Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)--core protein is mediated by toll like receptors (TLRs) 2 and 4.

Authors:  Uta Düesberg; Annette von dem Bussche; Carsten Kirschning; Kensuke Miyake; Tilman Sauerbruch; Ulrich Spengler
Journal:  Immunol Lett       Date:  2002-11-01       Impact factor: 3.685

View more
  12 in total

Review 1.  Toll-like receptors in innate immunity and infectious diseases.

Authors:  Min-Hao Wu; Ping Zhang; Xi Huang
Journal:  Front Med China       Date:  2010-12-02

2.  Hepatobiliary quiz (answers)-13 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-03-21

3.  Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation.

Authors:  Seung H Kang; Rima C Abdel-Massih; Robert A Brown; Ross A Dierkhising; Walter K Kremers; Raymund R Razonable
Journal:  J Infect Dis       Date:  2012-01-04       Impact factor: 5.226

Review 4.  Infections after orthotopic liver transplantation.

Authors:  Mark Pedersen; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2014-07-24

5.  Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia.

Authors:  U Schnetzke; B Spies-Weisshart; O Yomade; M Fischer; T Rachow; K Schrenk; A Glaser; M von Lilienfeld-Toal; A Hochhaus; S Scholl
Journal:  Genes Immun       Date:  2014-11-27       Impact factor: 2.676

6.  Association between TLR2 polymorphisms (- 196-174 Ins/Del, R677W, R753Q, and P631H) and schizophrenia in a Tunisian population.

Authors:  Youssef Aflouk; Oumaima Inoubli; Hana Saoud; Ferid Zaafrane; Lotfi Gaha; Besma Bel Hadj Jrad
Journal:  Immunol Res       Date:  2021-09-21       Impact factor: 2.829

Review 7.  Genetic variants of innate immune receptors and infections after liver transplantation.

Authors:  Gemma Sanclemente; Asuncion Moreno; Miquel Navasa; Francisco Lozano; Carlos Cervera
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 8.  Theoretical basis of a beneficial role for vitamin D in viral hepatitis.

Authors:  Khanh vinh quốc Lương; Lan Thi Hoàng Nguyễn
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

9.  The Role of TLR2 in Infection and Immunity.

Authors:  Laura Oliveira-Nascimento; Paola Massari; Lee M Wetzler
Journal:  Front Immunol       Date:  2012-04-18       Impact factor: 7.561

10.  TLR2 2258 G>A single nucleotide polymorphism and the risk of congenital infection with human cytomegalovirus.

Authors:  Wioletta Wujcicka; Edyta Paradowska; Mirosława Studzińska; Jan Wilczyński; Dorota Nowakowska
Journal:  Virol J       Date:  2017-01-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.